See how your Medicare performance compares with others in our
Stars Navigator Dashboard
Two new Medicare Part D Star Ratings measures - Polypharmacy-ACH (POLY-ACH) and Concurrent Use of Benzodiazepines and Opioids (COB) - highlight major safety concerns for older adults. When multiple prescribers are unaware of a member’s full medication list, dangerous overlaps occur, leading to overdoses, falls, hospitalizations, and lower Star Ratings.
Our polypharmacy programs safeguard members by identifying at-risk patients, engaging prescribers through omnichannel outreach, and supporting evidence-based deprescribing.
MAPD and PDP Contracts Supported
Growth in Managed Member Volume since 2024
Prescriber Engagement through Omnichannel Strategies
Prescribers Cataloged with Response History and Preferred Communication Channels
We identify at-risk members, engage prescribers across channels, and support evidence-based deprescribing to prevent overdoses, falls, and hospitalizations.
Through multichannel outreach, we connect with members and prescribers to drive safer prescribing while there's still time to impact the measure.
We guide prescribers through evidence-based deprescribing, offering clinical insights and follow-up support to ensure safer transitions.
We help members transition to safer, evidence-based therapies and navigate their plan benefits to ensure access and confidence in their care.
When members start filling interacting medications, we alert prescribers early to support safer therapy decisions before harm or measure failure occur.
At year-end, we target members who failed the measure, giving prescribers the runway needed to initiate deprescribing and ensure safer care moving forward.
Collaborating across prescribers, we streamline treatment, prevent medication overlap, and champion safe, evidence-based deprescribing.
Stay ahead with the latest news, insights, and innovations from MedWatchers, delivered straight to your inbox.
